Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Medicare gets Code J for Pemetrexed Injection

Written By Ruchika Sharma20 Jan 2024 12:30 PM IST

Shilpa's - NDA Pemetrexed Injection, is a novel ready-to-use injection which eliminates the need for reconstitution and dilution before administration...

Roche Q1 Sales Dip 5% on Currency Headwinds, Pins Hopes on New Drugs, Weight-Loss Entry

Roche gets European Commission marketing nod for Tecentriq SC for multiple cancer types

Written By Ruchika Sharma20 Jan 2024 11:24 AM IST

Basel: Roche has announced that the European Commission has granted marketing authorisation for Tecentriq SC (atezolizumab), the European Union (EU)'s...

Shilpa Biologicals, Stein Cares Ink Exclusive Biosimilar Licensing Pact for Latin America

Zydus, Synthon enter into licensing, supply agreement for Palbociclib Tablets for US market

Written By Ruchika Sharma19 Jan 2024 3:30 PM IST

Ahmedabad: Zydus Lifesciences Ltd., a global healthcare company announced that its wholly owned subsidiary, Zydus Worldwide DMCC, has entered...

With Union Budget 2024, medical devices cos hope for reduction in customs duties

Written By Ruchika Sharma19 Jan 2024 2:39 PM IST

New Delhi: Medical Technology Association of India (MTaI), an association of research-based medical technology companies, has said that...

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Lupin bags USFDA nod for hyperuricemia treatment drug Febuxostat

Written By Ruchika Sharma19 Jan 2024 1:30 PM IST

Mumbai: Global pharma major Lupin Limited has announced that the Company has received approval from the United States Food and Drug...

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

Cabinet approves MoU between India, Ecuador on cooperation in field of Medical Products Regulation

Written By Ruchika Sharma19 Jan 2024 12:30 PM IST

New Delhi: The Union Cabinet chaired by the Prime Minister, Shri Narendra Modi, was apprised of a Memorandum of Understanding signed on 07th...

Sun Pharma Seals Rs 97,500 Crore Organon Acquisition Deal

Sun Pharma gets non-exclusive rights to market second brand of Finerenone in India

Written By Ruchika Sharma19 Jan 2024 11:17 AM IST

Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa.

Aurobindo Pharma Gets USFDA Nod for OTC Dextromethorphan Polistirex ER Suspension

Aurobindo Pharma arm bags CDSCO panel recommendation for grant of marketing authorization of biosimilar trastuzumab

Written By Ruchika Sharma18 Jan 2024 3:10 PM IST

Hyderabad: In a recent BSE filing, Aurobindo Pharma has announced that CuraTeQ Biologics Pvt. Ltd., a wholly owned subsidiary of the...

Sanofis Thyrotropin Alfa Label Update: CDSCO Panel Recommends New Prescription Warning, Limits Sale to Specialists Only

USFDA updates Sanofi Dupixent label for atopic dermatitis

Written By Ruchika Sharma18 Jan 2024 3:00 PM IST

Paris: Sanofi has announced that the U.S. Food and Drug Administration (FDA) has updated the label for Dupixent (dupilumab) in atopic dermatitis,...

India AI-powered integrated digital health gateway ekincare raises investment from MSD IDEA Studio Asia Pacific

Natco Pharma invests around US$ 2 million in Cellogen Therapeutics

Written By Ruchika Sharma18 Jan 2024 12:30 PM IST

Hyderabad: Cellogen Therapeutics Private Limited, a Delhi based biotech startup promoted by Dr Gaurav Kharya, Director, Centre for Bone Marrow...

Zydus Told To Conduct Phase III Trial in India for Lurbinectedin Injection, BE Study Waived

Zydus Lifesciences secures USFDA nod for Pimavanserin capsules, tablets

Written By Ruchika Sharma18 Jan 2024 11:40 AM IST

Both the tablets and the capsules will be manufactured at the group's formulation manufacturing facility at Ahmedabad SEZ, India.

CDSCO Panel Flags Ethnic Variability, Seeks More Data from Takeda for Fruquintinib Hard Capsule Approval

Takeda Hyqvia gets USFDA nod for Chronic Inflammatory Demyelinating Polyneuropathy

Written By Ruchika Sharma17 Jan 2024 3:54 PM IST

Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved HYQVIA [Immune Globulin Infusion 10% (Human) with...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok